Respirology · 2018 · 28 citations · 20 references
MedicineInfectious DiseasesDiagnostic MicrobiologyMolecular DiagnosticsPulmonologyMycobacterial DiagnosticsPulmonary TuberculosisTuberculosis CareTuberculosis DiagnosisTuberculosis Diagnostic TestingDrug Resistance TestingEndobronchial TuberculosisGenexpert Mtb And Rif TestingRapid Molecular DiagnosticsRifampicin Resistance TestingTracheobronchial StenosisTuberculosis DiagnosticsTuberculosis Molecular Testing
BACKGROUND AND OBJECTIVE: Delayed diagnosis and treatment of tuberculosis (TB) contribute to poor outcomes, especially for endobronchial TB (EBTB), which typically leads to tracheobronchial stenosis. Finding rapid and accurate diagnostic tools for EBTB is crucial. GeneXpert Mycobacterium tuberculosis (MTB)/rifampin (RIF) was recommended by the World Health Organization (WHO) as a standard molecular biological diagnostic technique for MTB. The aim of this study was to evaluate the efficacy of GeneXpert MTB/RIF for diagnosing EBTB and for evaluating RIF resistance. METHODS: Biopsy tissue and bronchial brushings from EBTB patients were prospectively assessed with GeneXpert MTB/RIF. The diagnostic yields of auramine O-stained sputum smears and bronchial brush smears were obtained, and the results were compared with the cultures of sputum and biopsy tissues for MTB. RESULTS: In 61 confirmed cases of EBTB, the sensitivities of sputum smear, bronchial brush smear, sputum culture and tissue culture to diagnose EBTB were 13.1%, 32.8%, 36.1% and 68.9%, respectively. For bronchial brushings and biopsies, our data showed sensitivities of 57.4% and 63.9%, respectively, and a specificity of 100% for GeneXpert MTB/RIF, and these results were superior to those of sputum smears, bronchial brush smears and sputum culture. GeneXpert MTB/RIF for bronchial brushings and biopsies showed complementarity in its diagnostic performance. Resistance to RIF was identified in 17.4% (8/46) of GeneXpert MTB-positive cases. CONCLUSION: GeneXpert MTB/RIF may enable more rapid EBTB diagnosis and determination of RIF resistance, which are crucial for timely treatment.
20
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Catharina Boehme, Pamela Nabeta, Doris Hillemann et al. · New England Journal of Medicine · 2010 · 2.3K citations · Full text
Danica Helb, Martin Jones, Elizabeth Story‐Roller et al. · Journal of Clinical Microbiology · 2009 · 920 citations · Full text
Global Incidence of Multidrug‐Resistant Tuberculosis
Matteo Zignol, Mehran Hosseini, A Wright et al. · The Journal of Infectious Diseases · 2006 · 525 citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +16
Sezai Taşbakan, Cengiz Çavuşoğlu · Journal of Clinical Microbiology · 2011 · 365 citations · Full text